查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
胃腸藥物全球市場：按類型、藥物類別、給藥途徑、應用、分銷渠道、地區 - 規模、份額、展望、機會分析，2022-2030 年
市場調查報告書
商品編碼
1233340

胃腸藥物全球市場：按類型、藥物類別、給藥途徑、應用、分銷渠道、地區 - 規模、份額、展望、機會分析，2022-2030 年

Digestive Drugs Market, By Type, By Drug Class, By Route of Administration, By Application, By Distribution Channel, And by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

胃腸藥物用於緩解消化系統症狀，尤其是胃酸反流、消化不良和腸易激綜合徵 (IBS)。 它還用於治療其他嚴重疾病，如克羅恩病、潰瘍性結腸炎和食管裂孔疝。 常見的消化問題包括腹痛、腹脹、腹瀉、便秘和胃灼熱。 有用於治療各種消化系統疾病的消化療法。 例如，胃酸反流和消化不良可用雷尼替丁和奧美拉唑等抗酸劑治療。 更嚴重的病症，如潰瘍性結腸炎和克羅恩病，用布地奈德、美沙拉秦和潑尼松龍等藥物治療。 生產胃腸藥的大公司只有艾伯維、Alexion Pharmaceuticals、葛蘭素史克、Ironwood Pharmaceuticals 和 Janssen Pharmaceuticals 等幾家。

市場動態

進入胃腸藥市場的公司不斷推出新藥，這有助於胃腸藥市場的增長。 例如，2022 年 7 月，總部位於韓國的製藥公司 JW Pharmaceutical 推出了一種聯合消化藥物 Besticon。 它由阿爾維林檸檬酸鹽、西甲矽油和解痙藥組成。 Besticon 對患有腸易激綜合症、消化不良等胃腸道問題的患者有效。 同樣，2021 年 5 月，跨國製藥公司百時美施貴寶 (Bristol-Myers Squibb) 獲得美國食品藥品監督管理局 (FDA) 批准 Zeposia 用於治療嚴重活動性潰瘍性結腸炎 (UC)。 該藥物是一種鞘氨醇 1-磷酸 (S1P) 受體調節劑，可抑制淋巴細胞遷移至腸道。

這項研究的主要特點

  • 本報告對全球胃腸藥物市場進行了深入分析，以 2021 年為基準年，提供了預測期（2022-2030 年）的市場規模（美國）和復合年增長率 (CAGR%)。發布。
  • 它揭示了各個細分市場的潛在收入機會，並描述了該市場具有吸引力的投資建議矩陣。
  • 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
  • 它根據以下參數介紹了全球胃腸病學市場的領先企業，包括公司亮點、產品組合、主要亮點、財務業績和戰略。
  • 本研究涵蓋的主要公司包括：葛蘭素史克公司、艾伯維公司（艾爾建）、武田製藥有限公司、輝瑞公司、阿斯利康公司、Marksans Pharma、Tillotts Pharma AG、Salix Pharmaceuticals 和 Otsuka Pharmaceutical Co., Ltd ., Merck & Co., Inc., Lexicon Pharmaceuticals, Inc., Bayer AG, Cadila Healthcare Ltd.
  • 胃腸藥物全球市場報告面向行業內的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以通過用於分析全球胃腸藥物市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

  • 調查目的
  • 先決條件
  • 縮寫說明

第 2 章市場概述

  • 報告內容
    • 市場定義和範圍
  • 執行摘要
    • 市場概況：按類型分類
    • 市場概況：按藥物類別
    • 按給藥途徑劃分的市場概況
    • 市場概況：按應用分類
    • 市場概況：按分銷渠道
    • 市場概況：按地區
  • 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • 影響分析
  • 主要發展
  • 監管場景
  • 市場趨勢
  • 新產品發布
  • 監管場景
  • PORTER 的五力分析
  • 業務發展戰略
  • 流行病學
  • 疾病意識計劃
  • 治療安全性和療效分析
  • 管道解析

第 4 章全球胃腸藥物市場-冠狀病毒 (COVID-19) 大流行的影響

  • 對醫療保健的總體影響
  • 對消化道藥物生產及其市場需求的影響
  • COVID-19 流行病學

第 5 章全球胃腸病學市場，按類型，2017-2030

  • 品牌化
  • 通用的

第 6 章全球胃腸藥物市場，按藥物類別，2017-2030

  • 5-氨基水楊酸鹽
  • 胃腸道興奮劑
  • 瀉藥 (Lux
  • 抗酸劑
  • H2拮抗劑
  • 止瀉藥
  • 其他

第 7 章按給藥途徑劃分的全球胃腸藥物市場，2017-2030

  • 口語
  • 靜脈給藥
  • 其他

第 8 章全球胃腸病學市場：按應用分類，2017-2030

  • 胃食管反流病 (GERD)
  • 腸易激綜合徵
  • 潰瘍性結腸炎
  • 其他（慢性腹瀉、便秘等）

第 9 章全球胃腸藥物市場（按分銷渠道），2017-2030

  • 醫院藥房
  • 零售藥房
  • 在線藥店

第 10 章全球胃腸藥物市場，按地區劃分，2017-2030

  • 北美
  • 美國
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地區
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 意大利
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 東盟
  • 其他亞太地區
  • 中東
  • 海灣合作委員會
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中非
  • 南非

第11章競爭格局

  • 市場份額分析
    • GlaxoSmithKline plc
    • AbbVie Inc.（Allergan）
    • Takeda Pharmaceutical Company Limited
    • Pfizer Inc
    • AstraZeneca plc
    • Marksans Pharma
    • Tillotts Pharma AG
    • Salix Pharmaceuticals
    • Otsuka Pharmaceutical Co., Ltd.
    • Merck & Co., Inc.
    • Lexicon Pharmaceuticals, Inc.
    • Bayer AG
    • Cadila Healthcare Ltd.

第12章章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI5542

Digestive drugs are used to relieve gastrointestinal symptoms such as acid reflux, indigestion, and irritable bowel syndrome (IBS) among others. In addition, it is also used to treat other severe conditions such as Crohn's disease, ulcerative colitis, and hiatal hernia. The common digestive system diseases include symptoms such as abdominal pain, bloating, diarrhoea, constipation and heartburn. There are various gastrointestinal therapeutics that are used for treating various gastrointestinal conditions. For instance, acid reflux and indigestion are treated with antacids such as ranitidine and omeprazole. More severe conditions like ulcerative colitis and Crohn's disease are treated with medications such as budesonide, mesalazine and prednisolone. Few key market players manufacturing gastrointestinal drugs includes AbbVie, Alexion Pharmaceuticals, GlaxoSmithKline, Ironwood Pharmaceuticals and Janssen Pharmaceuticals among others.

Market Dynamics

Companies operating in digestive drugs market are launching new drugs which is contributing to growth of the digestive drugs market. For instance, in July 2022, JW Pharmaceutical, a South Korea based pharmaceutical company, launched Besticon a compound digestive medicine. It is composed of alverine citrate, simethicone and antispasmodic agent. Besticon is effective for patients suffering with irritable bowel syndrome, indigestion and other gastrointestinal issues. Similarly, in May 2021, Bristol Myers Squibb, a multinational pharmaceutical company received the U.S. Food and Drug Administration (FDA) approval for Zeposia for the treatment of severely active ulcerative colitis (UC). It is a sphingosine 1-phosphate (S1P) receptor modulator which reduces lymphocyte migration into the intestines.

Key features of the study:

  • This report provides an in-depth analysis of the global digestive drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global digestive drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include GlaxoSmithKline plc, AbbVie Inc. (Allergan), Takeda Pharmaceutical Company Limited, Pfizer Inc, AstraZeneca plc, Marksans Pharma, Tillotts Pharma AG, Salix Pharmaceuticals, Otsuka Pharmaceutical Co., Ltd., Merck & Co., Inc., Lexicon Pharmaceuticals, Inc., Bayer AG, Cadila Healthcare Ltd.
  • Global digestive drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global digestive drugs market

Detailed Segmentation:

  • Global Digestive Drugs Market, By Type
    • Branded
    • Generic
  • Global Digestive Drugs Market, By Drug Class
    • 5-aminosalicylates
    • GI stimulants
    • Laxatives
    • Antacids
    • H2 Antagonists
    • Antidiarrheals
    • Others
  • Global Digestive Drugs Market, By Route of Administration
    • Oral
    • Intravenous
    • Others
  • Global Digestive Drugs Market, By Application
    • Gastroesophageal Reflux Disease (GERD)
    • Irritable Bowel Syndrome
    • Ulcerative Colitis
    • Others (Chronic diarrhoea, constipation etc.)
  • Global Digestive Drugs Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Digestive Drugs Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • GlaxoSmithKline plc*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AbbVie Inc. (Allergan)
    • Takeda Pharmaceutical Company Limited
    • Pfizer Inc
    • AstraZeneca plc
    • Marksans Pharma
    • Tillotts Pharma AG
    • Salix Pharmaceuticals
    • Otsuka Pharmaceutical Co., Ltd.
    • Merck & Co., Inc.
    • Lexicon Pharmaceuticals, Inc.
    • Bayer AG
    • Cadila Healthcare Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Market Trends
  • New Product Launches
  • Regulatory Scenario
  • PORTER's Five Forces Analysis
  • Business Development Strategies
  • Epidemiology
  • Disease Awareness Programs
  • Treatment Safety and Efficacy Analysis
  • Pipeline Analysis

4. Global Digestive Drugs Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact on Healthcare
  • Impact on Digestive Drugs Manufacturing and Its Market Demand
  • COVID-19 Epidemiology

5. Global Digestive Drugs Market, By Type, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Branded
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Generic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Digestive Drugs Market, By Drug Class, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • 5-aminosalicylates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • GI stimulants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Laxatives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Antacids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • H2 Antagonists
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Antidiarrheals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Digestive Drugs Market, By Route of Administration, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

8. Global Digestive Drugs Market, By Application, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Gastroesophageal Reflux Disease (GERD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Irritable Bowel Syndrome
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Ulcerative Colitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others (Chronic diarrhoea, constipation etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

9. Global Digestive Drugs Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

10. Global Digestive Drugs Market, By Region, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Market Share Analysis
    • GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • AbbVie Inc. (Allergan)
    • Takeda Pharmaceutical Company Limited
    • Pfizer Inc
    • AstraZeneca plc
    • Marksans Pharma
    • Tillotts Pharma AG
    • Salix Pharmaceuticals
    • Otsuka Pharmaceutical Co., Ltd.
    • Merck & Co., Inc.
    • Lexicon Pharmaceuticals, Inc.
    • Bayer AG
    • Cadila Healthcare Ltd.
  • Analyst Views

12. Section

  • Research Methodology
  • About us